Literature DB >> 12679947

Ultrastructure and molecular biological changes of chronic gastritis, gastric cancer and gastric precancerous lesions: a comparative study.

Goang-Yao Yin1, Wu-Ning Zhang, Xiao-Jing Shen, Yi Chen, Xue-Fen He.   

Abstract

AIM: To carry out a comparative study on ultrastructure and molecular biological changes of chronic gastritis (CG), gastric cancer (GC) aand gastric precancerous lesions.
METHODS: By the use of histochemical staining, SEM with EDAX, TEM with EDAX, image analysis technique, RIA and chemiluminescence method, gastric mucosa of 168 patients were synchronously analyzed in morphology, trace elements, DNA, cAMP, SOD, (3)H-TdR LCT and serum LPO were also done.
RESULTS: The incidence of epithelial nucleoplasmic ratio >1, lobulated nuclei, inter-chromatin aggregation of granules, nucleolar hypertrophy, and the content of DNA, Zn, Cu in nuclei and serum LPO of each group were showed as belows: normal control group (0.0, 0.0, 6.7, 0.0, 12.6+/-2.7, 7.6+/-0.4, 58.4+/-0.3, 2.6+/-0.6), CSG group (5.7, 2.9, 7.4, 2.9, 15.2+/-3.1, 8.1+/-0.5, 58.9+/-0.5, 4.2+/-0.7), CAG group (31.3, 29.7, 45.3, 42.2, 16.5+/-3.1, 8.6+/-0.4, 59.3+/-0.5, 4.5+/-0.6), CA group (100.0, 100.0, 72.2, 50.0, 30.7+/-8.2, 8.8+/-0.3, 59.5+/-0.4, 6.8+/-1.6), ATP(++) group (61.5, 38.5, 23.1, 38.5, 23.5+/-8.9, 8.3+/-0.4, 59.1+/-0.4, 5.1+/-1.2), IM(++)+ATP(++)group (77.8, 55.5, 33.3, 44.4, 25.1+/-7.2, 8.4+/-0.5, 59.5+/-0.4, 6.5+/-1.1), IM(+++)+ATP(++) group (100.0, 100.0, 75.0, 62.5, 28.5+/-9.1, 8.9+/-0.5, 59.7+/-0.4, 7.6+/-0.7), IMII(b) group (100.0, 62.5, 75.0, 50.0, 27.3+/-10.3, 8.6+/-0.3, 59.5+/-0.4, 6.1+/-0.9); whereas the content of Zn, Cu in mitochondria and cAMP, SOD in gastric mucosa, and (3)H-TdR LCT of each group were showen as belows: normal control group (9.2+/-0.5, 58.3+/-0.3, 15.9+/-1.5, 170.5+/-6.1, 1079.7+/-227.4), CSG group (8.6+/-0.5, 57.8+/-0.3, 14.6+/-1.8, 163.3+/-5.6, 867.3+/-240.5), CAG group (8.3+/-0.4, 57.5+/-0.3, 13.4+/-1.8, 161.2+/-4.3, 800.9+/-221.8), CA group (8.9+/-0.4, 57.1+/-0.3, 10.2+/-3.9, 152.2+/-3.8, 325.7+/-186.8), ATP(++) group (9.1+/-0.4, 57.0+/-0.3, 12.4+/-1.8, 161.5+/-3.8, 642.9+/-174.3), IM(++)+ATP(++) group (8.6+/-0.4, 56.9+/-0.3, 12.0+/-2.3, 152.2+/-2.5, 326.3+/-160.3), IM(+++)+ATP(++) group (8.5+/-0.3, 56.8+/-0.2, 10.4+/-0.9, 147.4+/-2.6, 316.1+/-170.7), IMII(b) group (8.6+/-0.3, 56.9+/-0.3, 11.9+/-1.9, 150.0+/-2.8, 318.9+/-145.8), there were significant differences between groups (P<0.05-0.01).
CONCLUSION: There was a significant difference between CG and GC in their ultrastructure and molecular biology. Only on the condition of changes of internal environment in combination with the harmful effect of external environment, chronic atrophic gastritis can then develop into gastric cancer. Hence it might have similar epithelial cell ultrastructure and molecular biological changes in ATP(++), IMII(b) and cancer, hence there were similar patterns of occurrence, development and transformation. Recognition of this trend might help to explore problems of prevention and cure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679947      PMCID: PMC4611464          DOI: 10.3748/wjg.v9.i4.851

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  4 in total

1.  [Histocytopathological study on gastric mucosa of spleen deficiency syndrome].

Authors:  G Yin; W Zhang; X He
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  1999-11

2.  [Effect of Weikangfu granule on ultrastructure of gastric mucosa in patients of precancerosis with spleen deficiency syndrome].

Authors:  G Yin; W Zhang; F Xu
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2000-09

3.  [Therapeutic effect of weikangfu on gastric precancerous disorder with spleen deficiency syndrome and its effect of gastric mucosal zinc, copper, cyclic adenosine monophosphate, superoxide dismutase, lipid peroxide and 3H-TdR lymphocyte conversion test].

Authors:  G Yin; W Zhang; G Li
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2000-03

4.  [Study on mitochondrial ultrastructure, trace elements and correlative factors of gastric mucosa in patients with spleen deficiency syndrome].

Authors:  G Y Yin; X F He; Y F Yin
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  1995-12
  4 in total
  6 in total

1.  Effects of short-term application of low-dose growth hormone on trace element metabolism and blood glucose in surgical patients.

Authors:  Kun Qian; Zhi Wan; Lang-Song Hao; Ming-Ming Zhang; Yong Zhou; Xiao-Ting Wu
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

2.  Study on the classification of chronic gastritis at molecular biological level.

Authors:  Goang-Yao Yin; Wu-Ning Zhang; Xue-Fen He; Yi Chen; Xiao-Jing Shen
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

3.  Deficiency of the complex I of the mitochondrial respiratory chain but improved adenylate control over succinate-dependent respiration are human gastric cancer-specific phenomena.

Authors:  Marju Puurand; Nadežda Peet; Andres Piirsoo; Margot Peetsalu; Jaan Soplepmann; Meeli Sirotkina; Ants Peetsalu; Akseli Hemminki; Enn Seppet
Journal:  Mol Cell Biochem       Date:  2012-07-21       Impact factor: 3.396

4.  First ultrastructural observations on gastritis caused by Physaloptera clausa (Spirurida: Physalopteridae) in hedgehogs (Erinaceus europeaus).

Authors:  T Gorgani-Firouzjaee; A A Farshid; S Naem
Journal:  Parasitol Res       Date:  2015-06-27       Impact factor: 2.289

5.  Oxidative stress disturbs energy metabolism of mitochondria in ethanol-induced gastric mucosa injury.

Authors:  Jin-Shui Pan; Shao-Zhen He; Hong-Zhi Xu; Xiao-Juan Zhan; Xiao-Ning Yang; Hong-Min Xiao; Hua-Xiu Shi; Jian-Lin Ren
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

Review 6.  Cellular and mitochondrial effects of alcohol consumption.

Authors:  Salvador Manzo-Avalos; Alfredo Saavedra-Molina
Journal:  Int J Environ Res Public Health       Date:  2010-12-21       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.